Clinical Trial Update: Modified LCH-III Regimen With or Without Luvometinib for Multisystem Pediatric Langerhans Cell Histiocytosis [NA]

View source ↗

Summary

A clinical trial update indicates status is recruiting for a study of Modified LCH-III regimen with or without Luvometinib in pediatric multisystem Langerhans c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Langerhans Cell Histiocytosis

Drugs mentioned

• Luvometinib (Luvometinib)

Snippet

Sponsor: West China Second University Hospital | Conditions: Langerhans Cell Histiocytosis (LCH) | NA | Status: RECRUITING